Osaic Holdings
CLDI icon

Osaic Holdings’s Calidi Biotherapeutics CLDI Stock Holding History

Osaic Holdings’s Portfolio CLDI Stock Details CLDI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$503 Hold
2,106
– – ﹤0.01% 7436
2025
Q4 		$2.46K Buy
2,106
+1,706
+427% +$2.51K ﹤0.01% 7019
2025
Q3 		$377 Sell
400
-1,829
-82% -$7.77K ﹤0.01% 7595
2025
Q2 		$6.15K Buy
2,229
+625
+39% +$3.04K ﹤0.01% 6423
2025
Q1 		$10.9K Buy
1,604
+1,541
+2,446% +$17.6K ﹤0.01% 5737
2024
Q4 		$865 Buy
63
+42
+200% +$788 ﹤0.01% 6889
2024
Q3 		$288 Hold
21
– – ﹤0.01% 7112
2024
Q2 		$505 Hold
21
– – ﹤0.01% 6978
2024
Q1 		$1.44K Buy
+21
New +$2.15K ﹤0.01% 6588

Other funds holding CLDI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RCI
RS Crum Inc Newport Beach, California $517M AUM 16.68% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $3.54B AUM 19.14% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Osaic Holdings's CLDI Position: Q1 2026 in Review

Osaic Holdings held its Calidi Biotherapeutics (CLDI) position steady in Q1 2026 at 2,106 shares worth $503. The position accounts for ﹤0.01% of the portfolio, ranked #7436.

Osaic Holdings first reported a position in CLDI in Q1 2024 and has held it in 9 quarters since. The position peaked at $10.9K in Q1 2025. 28 funds tracked by Wall St. Rank hold CLDI as of Q1 2026.

  • Osaic Holdings held 2,106 shares of Calidi Biotherapeutics worth $503 as of Q1 2026.
  • Osaic Holdings left its Calidi Biotherapeutics share count unchanged in Q1 2026.
  • Calidi Biotherapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #7436 holding.
  • Osaic Holdings first reported a position in Calidi Biotherapeutics in Q1 2024 and has held it in 9 quarters since.
  • Osaic Holdings's Calidi Biotherapeutics position peaked at $10.9K in Q1 2025.
  • 28 funds tracked by Wall St. Rank held Calidi Biotherapeutics as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.